Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Randomized, phase II, placebo-controlled trial of onartuzumab and/or bevacizumab in combination with weekly paclitaxel in patients with metastatic triple-negative breast cancerV Diéras, M Campone, D A Yardley, et al.
Acta Neuropathologica|July 19, 2019
Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approachElan D Louis, Chloë A Kerridge, Debotri Chatterjee, et al.
Annals of Neurology|August 1, 1996
Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph diseaseI Lopes-Cendes, P Maciel, S Kish, et al.
Plos One|March 5, 2015
The pathogenesis of cardiomyopathy in Friedreich ataxiaArnulf H Koeppen, R Liane Ramirez, Alyssa B Becker, et al.
Human Molecular Genetics|April 6, 2000
Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31C M Coffeen, C E McKenna, A H Koeppen, et al.
Annals of Neurology|August 18, 2016
ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosisPan P Li, Xin Sun, Guangbin Xia, et al.
Transplantation|August 15, 1996
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppressionK A Newell, E M Alonso, P F Whitington, et al.
Plos Genetics|January 16, 2015
Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3Rui Gao, Yongping Liu, Anabela Silva-Fernandes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinomaB I Rini, L Albiges, X Tang, et al.
The Journal of Clinical Investigation|July 20, 1999
Safety and antitumor activity of recombinant soluble Apo2 ligandA Ashkenazi, R C Pai, S Fong, et al.
Pageof 12